Congratulations to our client, RedHill Biopharma Ltd. (NASDAQ: RDHL), a specialty biopharmaceutical company, on its private placement of ADSs and warrants for gross proceeds of $6 million.
Our team advising RedHill in this transaction included Perry Wildes, Ephraim Friedman and Ella Merhav of our International and Hi-Tech Department.
